Functional knockout of ATRX or DAXX permits the alternative lengthening of telomeres (ALT) mechanism in prostate cancer cells

被引：0
|
作者：
Graham, Mindy K.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3412
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3412
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Alternative lengthening of telomeres in cancer stem cells in vivo
    Bojovic, B.
    Booth, R. E.
    Jin, Y.
    Zhou, X.
    Crowe, D. L.
    ONCOGENE, 2015, 34 (05) : 611 - 620
  • [32] Alternative lengthening of telomeres in cancer stem cells in vivo
    B Bojovic
    R E Booth
    Y Jin
    X Zhou
    D L Crowe
    Oncogene, 2015, 34 : 611 - 620
  • [33] Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT)
    Sun, Haolu
    Chen, Guijuan
    Guo, Baochang
    Lv, Shushu
    Yuan, Guojun
    JOURNAL OF CANCER, 2023, 14 (03): : 417 - 433
  • [34] ALT control, delete: FANCM as an anti-cancer target in Alternative Lengthening of Telomeres
    O'Rourke, Julienne J.
    Bythell-Douglas, Rohan
    Dunn, Elyse A.
    Deans, Andrew J.
    NUCLEUS, 2019, 10 (01) : 221 - 230
  • [35] Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)
    De Vitis, Marco
    Berardinelli, Francesco
    Sgura, Antonella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [36] Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas.
    Becker, Aline P.
    Bell, Erica Hlavin
    Fleming, Jessica
    McElroy, Joseph P.
    Fabian, Denise
    Beyer, Sasha
    Salavaggione, Andrea L.
    Graham, Mindy K.
    Heaphy, Christopher M.
    Oehlke, Oliver
    Staszewski, Ori
    Prinz, Marco
    Grosu, Anca
    Chakravarti, Arnab
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)
    Mattiolo, Paola
    Bevere, Michele
    Mafficini, Andrea
    Verschuur, Anna Vera D.
    Calicchia, Martina
    Hackeng, Wenzel M.
    Simbolo, Michele
    Paiella, Salvatore
    Dreijerink, Koen M. A.
    Landoni, Luca
    Pedron, Serena
    Cingarlini, Sara
    Salvia, Roberto
    Milella, Michele
    Lawlor, Rita T.
    Valk, Gerlof D.
    Vriens, Menno R.
    Scarpa, Aldo
    Brosens, Lodewijk A.
    Luchini, Claudio
    ENDOCRINE PATHOLOGY, 2024, 35 (04) : 354 - 361
  • [38] Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells
    Xu, Yong
    Wang, Xiao
    Chen, Shi-Ming
    Chen, Chen
    Wang, Yan
    Xiao, Bo-Kui
    Tao, Ze-Zhang
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2016, 37 (06) : 552 - 558
  • [39] Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in nonfunctional pancreatic neuroendocrine tumors
    Mastrosimini, M. G.
    Manfrin, E.
    Remo, A.
    de Bellis, M.
    Pedron, S.
    Luchini, C.
    Brunelli, M.
    Ammendola, S.
    Pea, A.
    Landoni, L.
    Scarpa, A.
    Crino, S. F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 124 - 124
  • [40] The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications
    Recagni, Marta
    Bidzinska, Joanna
    Zaffaroni, Nadia
    Folini, Marco
    CANCERS, 2020, 12 (04)
12345